Zoetis Inc (NYSE: ZTS) is an animal health company that discovers, develops, manufactures, and commercializes medicines, vaccines, and diagnostics for livestock and companion animals. Revenue comes from transactional product sales across those three categories, sold to veterinarians, livestock producers, and distributors in markets worldwide. Zoetis was incorporated in Delaware in July 2012, having previously operated as a business unit of Pfizer Inc., and is headquartered at 10 Sylvan Way, Parsippany, New Jersey. The animal health market it operates in is segmented by meaningful regional differences in economic standards, cultural preferences around pet ownership and animal protein consumption, disease epidemiology, treatment adoption rates, and environmental factors, all of which shape demand across geographies. The company sells into both developed and emerging markets, with customer needs and product uptake varying materially by region.

Revenue model

Transactional product sales of animal health medicines, vaccines, and diagnostics to veterinarians, livestock producers, and distributors across global markets.

Products and services

Animal health medicines, vaccines, and diagnostics for companion animals and livestock, as disclosed in the FY2025 10-K filed 2026-02-12.

Customers and end markets

Veterinarians, livestock producers, and distributors across developed and emerging markets. End markets include companion animal care and livestock production, with demand shaped by pet ownership preferences, dietary protein consumption patterns, and regional disease dynamics.

Value-chain role

Manufacturer and commercial seller of animal health products. Operates from discovery and development through manufacturing and direct commercialization.

Geographic exposure

Global, with operations spanning developed markets and emerging markets. Regional demand varies by economic standards of living, cultural factors, and epidemiological conditions, per FY2025 10-K.

Source: SEC 10-K, filed 2026-02-12

Industry: Pharmaceutical Preparations Peers: Bristol-Myers Squibb Co Catalent, Inc. Eli Lilly and Co Johnson & Johnson Merck & Co Inc Organon & Co Pfizer Inc Royalty Pharma PLC Viatris Inc